Large-scale testing (Phase 3)Study completedNCT01112644
What this trial is testing
Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms
Who this might be right for
Moderate to Severe Idiopathic RLS With Daytime Symptoms
Mundipharma Research GmbH & Co KG 205